Track the RayzeBio, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 28 February 2024 (J). Among the most active insiders: VIKING GLOBAL INVESTORS LP. Every trade is openly available.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€208m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RayzeBio, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
30Σ signal
Buys n/a€208m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.